BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 7492819)

  • 1. [Paclitaxel (Taxol) and docetaxel (Taxotere): results of phase II trials in monochemotherapy].
    Fumoleau P; Perrocheau G; Maugard-Louboutin C; Lemevel B
    Bull Cancer; 1995 Aug; 82(8):629-36. PubMed ID: 7492819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
    Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
    Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
    Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
    Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel.
    Cortes JE; Pazdur R
    J Clin Oncol; 1995 Oct; 13(10):2643-55. PubMed ID: 7595719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxol (paclitaxel): a novel anti-microtubule agent with remarkable anti-neoplastic activity.
    Foa R; Norton L; Seidman AD
    Int J Clin Lab Res; 1994; 24(1):6-14. PubMed ID: 7910054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risks and benefits of taxanes in breast and ovarian cancer.
    Michaud LB; Valero V; Hortobagyi G
    Drug Saf; 2000 Nov; 23(5):401-28. PubMed ID: 11085347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
    Moon C; Verschraegen CF; Bevers M; Freedman R; Kudelka AP; Kavanagh JJ
    Anticancer Drugs; 2000 Aug; 11(7):565-8. PubMed ID: 11036959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel: a review of its pharmacology and clinical activity.
    Trudeau ME
    Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The scientific rationale for developing taxoids.
    Aapro M
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of taxanes in the treatment of breast cancer.
    Capri G; Tarenzi E; Fulfaro F; Gianni L
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects.
    Pronk LC; Stoter G; Verweij J
    Cancer Treat Rev; 1995 Sep; 21(5):463-78. PubMed ID: 8556719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The taxoids: paclitaxel and docetaxel.
    Gelmon K
    Lancet; 1994 Nov; 344(8932):1267-72. PubMed ID: 7967989
    [No Abstract]   [Full Text] [Related]  

  • 14. The taxoids. Comparative clinical pharmacology and therapeutic potential.
    Eisenhauer EA; Vermorken JB
    Drugs; 1998 Jan; 55(1):5-30. PubMed ID: 9463787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxoids: a new class of cytotoxic agents.
    Marty M; Extra JM; Giacchetti S; Cuvier C; Espie M
    Nouv Rev Fr Hematol (1978); 1994; 36 Suppl 1():S25-8. PubMed ID: 7909941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials.
    Sparano JA
    Clin Breast Cancer; 2000 Apr; 1(1):32-40; discussion 41-2. PubMed ID: 11899388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early clinical studies with docetaxel. Docetaxel Investigators Group.
    Aapro M; Bruno R
    Eur J Cancer; 1995; 31A Suppl 4():S7-10. PubMed ID: 7577102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer.
    Hudis CA; Seidman AD; Crown JP; Balmaceda C; Freilich R; Gilewski TA; Hakes TB; Currie V; Lebwohl DE; Baselga J; Raptis G; Gollub M; Robles M; Bruno R; Norton L
    J Clin Oncol; 1996 Jan; 14(1):58-65. PubMed ID: 8558221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of Taxotere (docetaxel) as a new treatment in breast cancer.
    Fumoleau P; Chevallier B; Kerbrat P; Dieras V; Azli N; Bayssas M; Van Glabbeke M
    Breast Cancer Res Treat; 1995; 33(1):39-46. PubMed ID: 7749131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel (Taxotere) in the treatment of solid tumors other than breast and lung cancer.
    Kaye SB
    Semin Oncol; 1995 Apr; 22(2 Suppl 4):30-3. PubMed ID: 7740329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.